Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy

The discovery of clustered regularly interspaced short palindromic repeats and CRISPR‐associated protein 9 (CRISPR‐Cas9) technology has brought advances in the genetic manipulation of eukaryotic cells, which has revolutionised cancer research and treatment options. It is increasingly being used in c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Immunology
Main Authors: Afolabi, Lukman O, Afolabi, Mariam O, Sani, Musbahu M, Okunowo, Wahab O, Yan, Dehong, Chen, Liang, Zhang, Yaou, Wan, Xiaochun
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8219901/
https://ncbi.nlm.nih.gov/pubmed/34188916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados